COMMUNIQUÉS West-GlobeNewswire

Novartis International AG: Global study by Novartis and European Migraine and Headache Alliance reveals 60% of employed people with severe migraine miss, on average, a week of work per month
27/06/2018
Study reveals migraine causes significant disruption to daily life and work, which could be managed with better preventive treatments and workplace solutions Migraine is estimated to cost up to €27 billion in Europe and [...]
Imagin Medical Announces Uplisting to OTCQB
27/06/2018
VANCOUVER, British Columbia and BOSTON, June 27, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTC PINK:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) is pleased to announce that its common [...]
Dr. Carrolee Barlow, M.D., Ph.D., Joins Supernus’ Board of Directors
27/06/2018
ROCKVILLE, Md., June 27, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
Neos Therapeutics Appoints Jerry McLaughlin as Chief Executive Officer
27/06/2018
Mr. McLaughlin brings decades of operational and commercial biopharmaceutical industry experience DALLAS and FORT WORTH, Texas, June 27, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical [...]
AIT Therapeutics Announces Human and In-Vitro Nitric Oxide Data to be Presented at the 3rd Annual World Bronchiectasis Conference
27/06/2018
Two presentations to highlight the direct killing effect of nitric oxide and the use of the nitric oxide generator and delivery system as a potential therapy for Mycobacterium abscessus complex (MABSC) lung infection [...]
Edge Therapeutics Announces Updated Results from Phase 3 NEWTON 2 Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
27/06/2018
Clinically meaningful benefit observed in NEWTON 2 primary endpoint in pre-specified WFNS 3 or 4 (severe) subgroup BERKELEY HEIGHTS, N.J., June 27, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today [...]
Inspire Medical Systems, Inc. Announces Regulatory Approval of Inspire Therapy for Treatment of Moderate to Severe Obstructive Sleep Apnea in Japan
27/06/2018
MINNEAPOLIS, June 27, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
CohBar Completes Sale of $20 Million Under Controlled Equity Offering
27/06/2018
MENLO PARK, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced that [...]
TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007
27/06/2018
REGULATED INFORMATION PRESS RELEASE Transparency notification pursuant to Article 14 of the Law of May 2, 2007 Leuven (Belgium) - June 27, 2018, 22:00h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG; "TiGenix") [...]
VBL Therapeutics Announces Closing of $15.5 Million Registered Direct Offering
27/06/2018
TEL AVIV, Israel, June 27, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Zafgen Announces Proposed Offering of Common Stock
27/06/2018
BOSTON, June 27, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
Kura Oncology Announces Commencement of Public Offering of Common Stock
27/06/2018
SAN DIEGO, June 27, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it has [...]
Zosano to Present Additional Analyses from the ZOTRIP Pivotal Study on Pain Relief and Recurrence at the 2018 American Headache Society (AHS) Meeting
27/06/2018
Key findings on receptor and binding kinetics also to be presented in a poster and oral presentation FREMONT, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma, a clinical-stage biopharmaceutical company dedicated [...]
GS Medical Announces New Product Launch and Successful Cadaver Workshop
27/06/2018
IRVINE, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- GS Solutions Inc., DBA GS Medical USA (GSM), a leader and innovator of surgeon-driven spinal technology that advances patient care, today announced the launch of the [...]
GENFIT: New Preclinical Data Shows Elafibranor Inhibits Development of NAFLD/NASH-Related Cancer
27/06/2018
GENFIT: New Preclinical Data Shows Elafibranor Inhibits Development of NAFLD/NASH-Related Cancer Elafibranor administration prevented liver tumor development in NAFLD/NASH disease models Elafibranor showed direct [...]
GENFIT : de nouvelles données précliniques montrent qu'elafibranor empêche le développement de cancers liés à la NAFLD/NASH
27/06/2018
GENFIT : de nouvelles données précliniques montrent qu'elafibranor empêche le développement de cancers liés à la NAFLD/NASH L'administration d'elafibranor a prévenu le développement de tumeurs du foie dans les modèles d [...]
Eight Genesis HealthCare Centers Earn 2018 Bronze National Quality Awards
27/06/2018
KENNETT SQUARE, Pa., June 27, 2018 (GLOBE NEWSWIRE) -- Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced that eight of its centers have been recognized as a 2018 [...]
Chula Vista Dentist Displays Fun New Light Show Outside Her Office
27/06/2018
CHULA VISTA, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- At Thompson Center for Dentistry, cosmetic dentist Uyen Thompson, DDS recently unveiled a unique lighting display on the outside of her practice. The decision to [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2018
27/06/2018
Communiqué de presse Villepinte, le 27 juin 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]

Pages